Retinoic acid (RA) and As <sub>2</sub> O <sub>3</sub> treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARα and PLZF-RARα oncoproteins

Proceedings of the National Academy of Sciences (2000) - Comments
pubmed: 10954752 doi: 10.1073/pnas.180290497 issn: 0027-8424 issn: 1091-6490

Eduardo M. Rego, Li-Zhen He, Raymond P. Warrell, Zhu-Gang Wang, Pier Paolo Pandolfi